Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05722015 |
|---|---|
| Brief Title: | A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) |
| First Submitted : | January 27, 2023 |
| First Submitted that Met QC Criteria : | January 27, 2023 |
| First Posted : | February 10, 2023 |
| Last Update Submitted that Met QC Criteria : | February 26, 2024 |
| Last Update Posted : | February 28, 2024 |